HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comment on: Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept.

AuthorsK A Binymin
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 46 Issue 11 Pg. 1741-2 author reply 1742-3 (Nov 2007) ISSN: 1462-0324 [Print] England
PMID17956919 (Publication Type: Comment, Letter)
Chemical References
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunoglobulins, Intravenous
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept
Topics
  • Antirheumatic Agents (therapeutic use)
  • Etanercept
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Immunoglobulins, Intravenous (therapeutic use)
  • Myocarditis (etiology)
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Still's Disease, Adult-Onset (complications)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: